Systolic Hypertension in the Elderly Program (SHEP). Part 7: Baseline laboratory characteristics.

作者信息

Hall W D, Davis B R, Frost P, Hoffmeier M, O'Brien J E, Pace S, Page L, Schneider K A, Stamler J

出版信息

Hypertension. 1991 Mar;17(3 Suppl):II102-22. doi: 10.1161/01.hyp.17.3_suppl.ii102.

DOI:10.1161/01.hyp.17.3_suppl.ii102

PMID:1999369

Abstract

摘要

相似文献

Systolic Hypertension in the Elderly Program (SHEP). Part 7: Baseline laboratory characteristics.

Hypertension. 1991 Mar;17(3 Suppl):II102-22. doi: 10.1161/01.hyp.17.3_suppl.ii102.

Systolic Hypertension in the Elderly Program (SHEP). Part 8: Electrocardiographic characteristics.

Hypertension. 1991 Mar;17(3 Suppl):II123-51. doi: 10.1161/01.hyp.17.3_suppl.ii123.

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

Arch Intern Med. 1998 Apr 13;158(7):741-51. doi: 10.1001/archinte.158.7.741.

Systolic Hypertension in the Elderly Program (SHEP). Part 5: Baseline blood pressure and pulse rate measurements.

Hypertension. 1991 Mar;17(3 Suppl):II62-76. doi: 10.1161/01.hyp.17.3_suppl.ii62.

Systolic Hypertension in the Elderly Program (SHEP). Part 6: Baseline physical examination findings.

Hypertension. 1991 Mar;17(3 Suppl):II77-101. doi: 10.1161/01.hyp.17.3_suppl.ii77.

Clinical trial participant satisfaction: survey of SHEP enrollees. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program.

J Am Geriatr Soc. 1997 Aug;45(8):934-8. doi: 10.1111/j.1532-5415.1997.tb02962.x.

Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.

J Hum Hypertens. 1991 Dec;5(6):469-74.

[Influence of over-weight and obesity on blood pressure, blood sugar, lipid and uric acid in elderly people].

Hunan Yi Ke Da Xue Xue Bao. 2000 Jun 28;25(3):299-300.

Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study.

Hypertension. 2006 Dec;48(6):1037-42. doi: 10.1161/01.HYP.0000249768.26560.66. Epub 2006 Oct 23.

Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.

J Diabetes Res. 2019 Dec 4;2019:3175418. doi: 10.1155/2019/3175418. eCollection 2019.

引用本文的文献

Pharmacotherapy for mild hypertension.

Cochrane Database Syst Rev. 2025 Sep 24;9(9):CD006742. doi: 10.1002/14651858.CD006742.pub3.

Pharmacotherapy for hypertension in adults 60 years or older.

Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD000028. doi: 10.1002/14651858.CD000028.pub3.

First-line drugs for hypertension.

Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3.

Pharmacotherapy for mild hypertension.

Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD006742. doi: 10.1002/14651858.CD006742.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验